Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Mar 24.

Published in final edited form as: Biomaterials. 2010 May 15;31(23):6031–6038. doi: 10.1016/j.biomaterials.2010.04.009

Fig. 4 — %AChE activity (AChE activity after x days/AChE activity for healthy rat at day 0) (Mean ± SD, n = 8) in hippocampus at day 0 (▭) and after 3 ( ), 7 ( ), 10 (▬), 14 ( ), 21 ( ), 28 ( ) and 35 days ( ). Rats received daily subcutaneous injections of ET-saline-1.5, and two organogel formulation injections (at day 0): ET-BTM-300-15 and ET-BTM-500-25. (*) p < 0.05.

Inline graphic — %AChE activity (AChE activity after x days/AChE activity for healthy rat at day 0) (Mean ± SD, n = 8) in hippocampus at day 0 (▭) and after 3 ( ), 7 ( ), 10 (▬), 14 ( ), 21 ( ), 28 ( ) and 35 days ( ). Rats received daily subcutaneous injections of ET-saline-1.5, and two organogel formulation injections (at day 0): ET-BTM-300-15 and ET-BTM-500-25. (*) p < 0.05.